Cytokinetics Executives Sell and Buy Shares Amid Market Volatility

Cytokinetics Inc. (CYTK) has disclosed various transactions involving its directors and executive officers. Director Robert Arthur Harrington sold 2,150 shares at $66.80 each on December 1, 2025. Director John T. Henderson sold 8,750 shares at $63.90 each on the same day, but subsequently purchased 8,750 shares at $10.00 each on December 2, 2025. Director Edward M. Kaye, MD sold 28,064 shares at $66.72 each on December 1, 2025, and subsequently purchased 8,064 shares at $12.40 each on the same day, as well as 20,000 shares at $14.25 each on December 1, 2025. EVP Research & Development Fady Ibraham Malik purchased 2,200 shares at $10.60 each on December 2, 2025, and sold an equal number of shares at $63.89 each on the same day.